Sugi Predict

Sugi Predict / Compounds / SCHEMBL9609775

SCHEMBL9609775

SCHEMBL9609775

Cc1ccc(=O)n(CC(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ MAPT P10636 2/20 0.55
▸ POLB P06746 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ RGS4 P49798 1/20 0.39
▸ RGS8 P57771 1/20 0.39
▸ BMPR1B O00238 1/20 0.39
▸ BMPR1A P36894 1/20 0.39
▸ TGFBR1 P36897 1/20 0.39
▸ ACVRL1 P37023 1/20 0.39
▸ ACVR1 Q04771 1/20 0.39
▸ NR1D1 P20393 1/20 0.37
▸ ICMT O60725 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14407049 0.85 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL14407048 0.85 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL11929546 0.85 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL16075164 0.82 KDM4E (0.53) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL2636371 0.81 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL20197193 0.78 BMPR1B (0.38) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL2608967 0.78 MAPT (0.46) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL1468537 0.78 NPC1 (0.39) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL11983452 0.77 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTPOLBHSD17B10
SCHEMBL18102201 0.77 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022078403-A1 SUBSTITUTED PYRIDONE COMPOUND AND APPLICATION 江苏先声药业有限公司 2022-04-21 — — WO disclosed
WO-2021139775-A1 PYRIDONE COMPOUND AND APPLICATION 江苏先声药业有限公司 2021-07-15 — — WO disclosed
US-9670172-B2 Heterocyclic compounds and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2017-06-06 — — US disclosed
US-20150065519-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE MEDIVATION TECHNOLOGIES LLC 2015-03-05 — — US disclosed
US-8921243-B2 Fabrics comprising a photocatalyst to produce singlet oxygen from ambient oxygen VENTANA RESEARCH CORPORATION 2014-12-30 — — US disclosed
US-8921243-B2 Fabrics comprising a photocatalyst to produce singlet oxygen from ambient oxygen VENTANA RESEARCH CORPORATION 2014-12-30 — — US disclosed
US-8481446-B2 Chemically-resistant coating composition VENTANA RESEARCH CORPORATION 2013-07-09 — — US disclosed
US-8481446-B2 Chemically-resistant coating composition VENTANA RESEARCH CORPORATION 2013-07-09 — — US disclosed
US-8367662-B2 Organic compounds NOVARTIS AG (CH) 2013-02-05 — — US disclosed
US-8367662-B2 Organic compounds NOVARTIS AG (CH) 2013-02-05 — — US disclosed
EP-2212323-B1 IMIDAZO [1,2-A] PYRIDINE DERIVATIVES USEFUL AS ALK INHIBITORS NOVARTIS AG (CH) 2012-08-15 — — EP disclosed
US-20120135651-A1 Fabrics Comprising a Photocatalyst to Produce Singlet Oxygen from Ambient Oxygen VENTANA RESEARCH CORPORATION 2012-05-31 — — US disclosed
US-20120135651-A1 Fabrics Comprising a Photocatalyst to Produce Singlet Oxygen from Ambient Oxygen VENTANA RESEARCH CORPORATION 2012-05-31 — — US disclosed
WO-2011142838-A2 CHEMICALLY-RESISTANT COATING COMPOSITION LOMBARID JOHN L (US) 2011-11-17 — — WO disclosed
US-20100279850-A1 CHEMICALLY-RESISTANT COATING COMPOSITION VENTANA RESEARCH CORPORATION 2010-11-04 — — US disclosed
US-20100279850-A1 CHEMICALLY-RESISTANT COATING COMPOSITION VENTANA RESEARCH CORPORATION 2010-11-04 — — US disclosed
WO-2010118180-A1 FABRICS COMPRISING A PHOTOCATALYST TO PRODUCE SINGLET OXYGEN FROM AMBIENT OXYGEN LOMBARDI JOHN L (US) 2010-10-14 — — WO disclosed
US-20100210641-A1 Organic Compounds NOVARTIS AG (CH) 2010-08-19 — — US disclosed
US-20100210641-A1 Organic Compounds NOVARTIS AG (CH) 2010-08-19 — — US disclosed
WO-2009050183-A2 IMIDAZO [1, 2-A] PYRIDINE DERIVATIVES USEFUL AS ALK INHIBITORS NOVARTIS AG (CH) 2009-04-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210641-A1 Organic Compounds ALK, ACVR1, ACVRL1 ALDH1A1 1069/4885KDM4E 448/4885MAPT 2453/4885
US-20150065519-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE HRAS, VHL, ESRRB ALDH1A1 2384/4885KDM4E 3356/4885MAPT 4672/4885
US-20100279850-A1 CHEMICALLY-RESISTANT COATING COMPOSITION DNMT1, VCL, DNMT3L ALDH1A1 1103/4885KDM4E 173/4885MAPT 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.